Rac guanosine triphosphatases represent a potential target in AML.
Müller
L U W
LU
Schore
R J
RJ
Zheng
Y
Y
Thomas
E K
EK
Kim
M-O
MO
Cancelas
J A
JA
Gu
Y
Y
Williams
D A
DA
D000634:Aminoquinolines; D000818:Animals; D002453:Cell Cycle / Q000187:drug effects; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D016503:Drug Delivery Systems; D004354:Drug Screening Assays, Antitumor; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D051379:Mice; D011743:Pyrimidines; D015996:Survival Rate; D014183:Transplantation, Heterologous; D020744:rac GTP-Binding Proteins / Q000037:antagonists & inhibitors*
D000634:Aminoquinolines; D004791:Enzyme Inhibitors; C487513:NSC 23766; D011743:Pyrimidines; D020744:rac GTP-Binding Proteins